Table 2. Statistically Relevant Compounds Found Using MS-DIAL and patRoona.
| post-hoc p-values |
ANOVA | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| chemical name | rt (min) | m/z** | LC mode | IL | HMDB category | PubChem pathways | library/database/suspect list | MCI-AD | ND-AD | ND-MCI | p-value |
| valine | 6.99 | 118.0862 | HILIC (+) | 1 | exogenous | yes | PCL/AD-database | 0.9991 | 0.0320* | 0.0293* | 0.0156* |
| proline | 6.93 | 116.0706 | HILIC (+) | 1 | endogenous | yes | PCL/AD-database | 0.1432 | 0.7350 | 0.0303* | 0.0325* |
| N-acetylhistidine | 8.14 | 198.0872 | HILIC (+) | 2a | endogenous, exogenous | no | MSDIAL-MSPs | 0.4226 | 0.3859 | 0.0374* | 0.0477* |
| 3-hydroxybutanoic acid (BHBA) | 5.92 | 103.0396 | HILIC (−) | 1 | endogenous | yes | MSDIAL-MSPs | 0.0042* | 0.0150* | 0.8637 | 0.0030* |
| indole-3-acetic acid (IAA) | 13.66 | 176.0706 | RPLC (+) | 1 | endogenous | yes | PCL/AD-database/SC20/HMDB-CSF | 0.7248 | 0.0390* | 0.0064* | 0.0061* |
| 4-hydroxyphenyl lactic acid (4-HPLA) | 6.46 | 181.0495 | HILIC (−) | 2a | endogenous, exogenous | no | MSDIAL-MSPs | 0.9935 | 0.0574 | 0.0455* | 0.0285* |
| adenine | 3.42 | 136.0617 | HILIC (+) | 1 | endogenous | yes | MSDIAL-MSPs | 0.9958 | 0.0213* | 0.0174* | 0.0091* |
| cytosine | 5.90 | 112.0505 | HILIC (+) | 2a | endogenous | yes | MSDIAL-MSPs | 0.0216* | 0.6122 | 0.1575 | 0.0253* |
| galacturonic acid | 12.24 | 193.0342 | HILIC (−) | 1 | endogenous | yes | MSDIAL-MSPs | 0.9534 | 0.0753 | 0.0403* | 0.0305* |
| threonic acid | 10.48 | 135.0291 | HILIC (−) | 1 | endogenous | no | MSDIAL-MSPs | 0.4707 | 0.3345 | 0.0361* | 0.0457* |
| cotinine | 1.76 | 177.1021 | HILIC (+) | 1 | endogenous | no | MSDIAL-MSPs | 0.0915 | 0.8744 | 0.0320* | 0.0284* |
| diazepam | 17.11 | 285.0787 | RPLC (+) | 2a | exogenous | no | MSDIAL-MSPs | 0.0373* | 0.6052 | 0.2429 | 0.0447* |
Only Level 1 and Level 2a annotations are included. *p-value < 0.05. **Adducts were [M + H]+ for (+) and [M – H]− for (−) mode. IL: identification level. See Tables S8–S10 and Figure S11 for detailed information.